PPP1R3A and Epstein-Barr virus infection: Our results will facilitate efficient experimental efforts, as the three different envelope glycoproteins of EBV strains B95-8 and AG876 (i.e., gB, gH, and gM) could be used for construction of the vaccine by conjugating the epitopes (CTL, HTL, and LBL epitopes), whereas previously only single epitope-based peptide vaccines were proposed to fight against EBV infection.